Keywords: USA, FDA, PDUFA dates, Bydureon, Peginesatide, Amylin, Eli Lilly, Alkermes, Affymax, Takeda, Type 2 diabetes, Anemia, Kidney disease

US FDA sets PDUFA action dates for Bydureon and peginesatide

Article | 12 August 2011

Print This

US drugmakers Amylin Pharmaceuticals (Nasdaq: AMLN), Eli Lilly (NYSE: LLY) and Alkermes (Nasdaq: ALKS) said yesterday that the US Food ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in